| P2093 | author name string | Aminah Jatoi | |
| | Jason D Doles | |
| | Adrienne Samani | |
| | Kelly A Hogan | |
| | Paige C Arneson | |
| | Alexandra M Shin | |
| P2860 | cites work | SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways | Q24296915 |
| | PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis | Q24798075 |
| | Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance | Q27335066 |
| | Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase | Q28302589 |
| | STAR: ultrafast universal RNA-seq aligner | Q29615052 |
| | From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. | Q30361595 |
| | Inflammation based regulation of cancer cachexia | Q33615916 |
| | Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 |
| | Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy | Q33702390 |
| | Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins | Q33792533 |
| | Treatment of cachexia in oncology | Q34158188 |
| | Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors | Q34279708 |
| | The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote | Q34337291 |
| | MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing | Q34494158 |
| | Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis | Q34517912 |
| | Disorders caused by deficiency of succinate-CoA ligase | Q34768203 |
| | The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells | Q35060787 |
| | Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice | Q35063242 |
| | Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism | Q35067274 |
| | An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration | Q35154984 |
| | Pervasive satellite cell contribution to uninjured adult muscle fibers | Q36367465 |
| | Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People | Q36716070 |
| | The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting | Q36901945 |
| | Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia | Q36934990 |
| | RETRACTED ARTICLE: Alpha-ketoglutarate promotes skeletal muscle hypertrophy and protein synthesis through Akt/mTOR signaling pathways | Q36937714 |
| | Impaired regeneration: A role for the muscle microenvironment in cancer cachexia | Q37042189 |
| | NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia | Q37259234 |
| | Two transgenic mouse models for β-subunit components of succinate-CoA ligase yielding pleiotropic metabolic alterations | Q37449919 |
| | A metabolic link to skeletal muscle wasting and regeneration | Q37541118 |
| | Cause and management of muscle wasting in chronic liver disease | Q38773837 |
| | Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells | Q38930866 |
| | The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity | Q39129064 |
| | The Close Interconnection between Mitochondrial Dynamics and Mitophagy in Cancer. | Q39312378 |
| | α-Ketoglutarate Accelerates the Initial Differentiation of Primed Human Pluripotent Stem Cells | Q39540477 |
| | Mitochondrial fission and remodelling contributes to muscle atrophy. | Q39713513 |
| | The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle | Q40190344 |
| | Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation | Q40263549 |
| | Muscle stem cells contribute to myofibres in sedentary adult mice | Q40789586 |
| | Interactions between bioenergetics and mitochondrial biogenesis | Q41015290 |
| | Mitochondrial biogenesis during cellular differentiation | Q41118321 |
| | Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation | Q41146515 |
| | Effects of succinate on amino acid incorporation into protein during chemical carcinogenesis | Q41573799 |
| | Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. | Q42262778 |
| | Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency. | Q42350705 |
| | Serum from human burn victims impairs myogenesis and protein synthesis in primary myoblasts | Q42430756 |
| | Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival | Q42932180 |
| | Oxidative stress impairs skeletal muscle repair in diabetic rats. | Q44816760 |
| | Muscle regeneration during hindlimb unloading results in a reduction in muscle size after reloading | Q44875527 |
| | Measuring Mitochondrial Function in Permeabilized Cells Using the Seahorse XF Analyzer or a Clark-Type Oxygen Electrode | Q46137719 |
| | Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist | Q46635433 |
| | Skeletal muscle satellite cell activation following cutaneous burn in rats. | Q46692767 |
| | Overcoming obstacles in the design of cancer anorexia/weight loss trials | Q47194265 |
| | Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment | Q47446603 |
| | Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia | Q47605033 |
| | Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017. | Q47664420 |
| | MyoVision: software for automated high-content analysis of skeletal muscle immunohistochemistry | Q47855007 |
| | Role of Activin A and myostatin in human cancer cachexia | Q48046698 |
| | Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse. | Q51832285 |
| | MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. | Q55518708 |
| | Mitochondria as a potential regulator of myogenesis. | Q55619121 |
| | Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model | Q57183649 |
| | Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration | Q57275370 |
| | Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients | Q60141788 |
| | The effect of succinate on brain NADH/NAD+ redox state and high energy phosphate metabolism in acute traumatic brain injury. | Q64884036 |
| | The role of succinate in the regulation of fatty acid synthesis by heart mitochondria | Q68723786 |
| | Chloramphenicol, an inhibitor of mitochondrial protein synthesis, inhibits myoblast fusion and myotube differentiation | Q70733990 |
| | Glutamine and α-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement | Q72039549 |
| | Quantitative study of the effects of long-term denervation on the extensor digitorum longus muscle of the rat | Q73492191 |
| | Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells | Q80492249 |
| | [Pax7 and depletion of satellite cell pool in prolonged denervated skeletal muscles of adult rats] | Q83295524 |
| P433 | issue | 2 | |
| P304 | page(s) | 56-69 | |
| P577 | publication date | 2020-06-02 | |
| P1476 | title | The wasting-associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration | |
| P478 | volume | 3 | |